4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-13-018376
$MDGLCIK 0001157601operating
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:23 PM ET
Size
6.9 KB
Accession
0001179110-13-018376
Insider Transaction Report
Form 4
Bernitz Steven B
SVP, Corporate Development
Transactions
- Award
Common Stock
2013-12-18$0.00/sh+25,000$3→ 25,000 total - Award
Employee Stock Option (Right to Buy)
2013-12-18+150,000→ 150,000 totalExercise: $4.34Exp: 2023-12-18→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of December 18, 2015 and December 18, 2016, provided the Reporting Person remains employed by the Issuer on such date.
- [F2]The option vests as to 25% of the shares on Decmeber 18, 2014 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:23 PM ET
- Size
- 6.9 KB